OncoTargets and Therapy (Sep 2020)

MicroRNA-623 Inhibits Epithelial–Mesenchymal Transition to Attenuate Glioma Proliferation by Targeting TRIM44

  • Cui D,
  • Wang K,
  • Liu Y,
  • Gao J,
  • Cui J

Journal volume & issue
Vol. Volume 13
pp. 9291 – 9303

Abstract

Read online

Dawei Cui,1 Kaijie Wang,2 Yan Liu,2 Junling Gao,3 Jianzhong Cui1,2 1Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei 050017, People’s Republic of China; 2Department of Surgery, Tangshan Gongren Hospital, Tangshan, Hebei, 063000, People’s Republic of China; 3School of Basic Medical Science, North China University of Science and Technology, Tangshan, Hebei 063200, People’s Republic of ChinaCorrespondence: Jianzhong CuiDepartment of Surgery, Hebei Medical University, Shijiazhuang, Hebei 050017, People’s Republic of ChinaEmail [email protected]: Glioma has the highest incidence among the different tumor types within the nervous system, accounting for about 40% of them. Malignant glioma has a high invasion and metastasis rate, which leads to the poor prognosis of patients. By targeting specific genes, microRNAs serve as key regulators in the epithelial–mesenchymal transformation (EMT) process, which could provide new insights into the treatment of glioblastomas (GBM). The detailed molecular role that miR-623 plays in GBM still remains unclear.Materials and Methods: The level of miR-623 in GBM cells was evaluated by RT-PCR. The function of miR-623 overexpression on GBM cell proliferation, migration, and invasion was assessed by MTS, Transwell analysis, and colony formation assay. In addition, a mouse subcutaneous xenograft model was used to study in vivo effects. The binding between miR-623 and TRIM44 was verified by a dual-luciferase reporter assay and the regulatory function of miR-623 on EMT markers was evaluated using Western blot.Results: The expression of miR-623 was repressed in the GBM cancer cell lines. MiR-623 overexpression or TRIM44 knockdown attenuated the proliferation, migration, and invasion of GBM cell lines. TRIM44 could facilitate the reverse suppression of EMT and miR-623 in GBM progression. MiR-623 was found to inhibit TRIM44 expression by directly binding to its 3ʹUTR. In addition, systemic delivery of miR-623 mimic reduced tumor growth and inhibited TRIM44 protein expression in tumor-bearing nude mice. Furthermore, our findings indicated that miR-623 overexpression or TRIM44 down-regulation impeded the proliferation and migratory ability of LN229 and U251MG glioma cells, and miR-623 attenuates TRIM44-induced EMT by directly targeting the 3ʹUTR of TRIM44, which could serve as preliminary research to identify potential therapeutic targets for future treatment of GBM.Conclusion: Overall, microRNA-623 inhibits epithelial–mesenchymal transition to attenuate glioma proliferation by targeting TRIM44.Keywords: GBM, hsa-miR-623, TRIM44, proliferation, EMT

Keywords